Harvard Dementia A Comprehensive Update 2026 is listed here as a digital educational resource. Read the program context and purchase limitations below before ordering.
Course Context
Harvard Medical School’s published schedule dates this program to May 27–30, 2026. It addresses cognitive impairment and dementia through a multidisciplinary clinical review.
Program Overview
The official agenda covers cognition, memory, Alzheimer’s disease and related disorders.
Assessment and Biomarkers
Topics include mild cognitive impairment, blood biomarkers and imaging-based assessment.
Dementia Syndromes
Sessions address frontotemporal, vascular, Lewy body and Parkinsonian presentations.
Cognitive Evaluation
Neuropsychology, everyday function and practical cognitive assessment appear in the schedule.
Treatment Discussions
The agenda includes experimental therapeutics and case discussions of lecanemab and donanemab.
Behavioral Symptoms
Drug and non-drug approaches to behavioral problems are discussed.
Caregiving
Caregiver impact and community advocacy are included.
Additional Conditions
Other sessions consider chronic traumatic encephalopathy, delirium and uncommon dementias.
Ethics and Safety
Diagnostic disclosure, capacity, legal issues and driving safety are addressed.
Advanced Care
End-stage dementia, advance planning, palliation and hospice are included.
Study Use
Use the supplied materials for educational review. This listing does not promise clinical competence, patient outcomes or professional credentials.
Before You Purchase
Confirm the supplied file formats, session coverage, language and subtitles before ordering. The organizer’s agenda is not a verified inventory of the files delivered by this store. No Harvard registration, learning-platform account, live participation, CME points or certificate is included.
Intended Audience
Health professionals involved in assessing or caring for people with cognitive impairment.
Official Program Reference
Harvard Medical School: Dementia: A Comprehensive Update. The published 2026 schedule supports the brief topic summary above; access terms for registered participants do not establish store purchase entitlements.



